Number of Shares
-40,178.00
Current Holdings Value*
$-2.92 Mil
% of Portfolio
-7.69%
Total Estimate Gain
$2.01 Mil
% of Total Estimate Gain
34.56%

K2 Alternative Strategies Fund's iShares U.S. Pharmaceuticals ETF Holding Summary

As of 2025-02-28, K2 Alternative Strategies Fund held -40,178.00 shares of iShares U.S. Pharmaceuticals ETF(IHE), totaling $-2.92 Mil. This investment constitutes -7.69% of their stock portfolio, and K2 Alternative Strategies Fund now holds -0.46% of the outstanding iShares U.S. Pharmaceuticals ETF(IHE) stock.

The initial trade took place in 2023Q4. And since then K2 Alternative Strategies Fund has made 3 purchases of IHE, at an average price of $67.40, for a total of 86,148.00 shares. In addition, there have been 3 sales at an average price of $61.85 for 126,326.00 shares. Based on historical transaction data and IHE's current price of $67.36, K2 Alternative Strategies Fund's estimated gain on his IHE holdings is $2.01 Mil, reflecting a 34.56% gain to date.

K2 Alternative Strategies Fund IHE ($67.36) Holding Chart

K2 Alternative Strategies Fund IHE ($67.36) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1